Bifido, the first listed company in the microbiome field, announced on the 13th that a patent has been granted for a composition developed with its proprietary probiotics that can improve, prevent, ...

Bifido (238200) has delivered a 5% change over the past year, with a 52-week range between 2,895 and 4,390. What Is the Average Daily Trading Volume of Bifido (238200)? The average daily trading ...

Bifido has received government support and plans to accelerate the GRAS certification of the ‘ND88’ strain. Bifido, a microbiome specialist company based on Bifidobacterium (CEOs Shin Yong-cheol and ...

US stock futures held steady after a volatile day of trading ended in a rally, driven by President Donald Trump's one-month pause on tariffs targeting automakers. Madison Mills examines the trending ...

Visit a quote page and your recently viewed tickers will be displayed here.

Bifido share technical analysis data. Assess 238200 stock's detailed technical analysis based on the buy/sell signals of moving averages (simple and exponential for a wide range of periods) and buy, ...

BIFIDO Co., Ltd reported earnings results for the full year ended December 31, 2022. For the full year, the company reported negative sales was KRW 0.00007 million compared to sales of KRW 0.00028 ...

Bifido Co. Ltd. engages in the manufacturing of probiotics raw and finished products. It offers probiotics products, such as probiotics strains (raw material), probiotics for human, probiotics for ...

Find the latest BIFIDO Co., Ltd. (238200.KQ) stock quote, history, news and other vital information to help you with your stock trading and investing.